pharmaphorum | News & views on pharma and biotech’s evolving …
WEBpharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
Revolutionising clinical trials: The promise of AI-driven subgroup ...
WEB1 day ago · Discover how AI-driven subgroup analysis is revolutionising clinical trials, offering new insights and potential breakthroughs in medical research. Stay informed about the latest advancements in ...
Investment outlook: Key takeaways from LSX USA | pharmaphorum
WEB16 hours ago · Discover the key takeaways from the LSX USA Congress with this podcast wrap-up, offering insights into investment outlook and trends discussed at the event.
Deep Dive: Oncology 2024 | pharmaphorum
WEBSep 26, 2024 · Explore the future of oncology in 2024, including advancements in CAR-T therapies, support for cancer survivors, and the latest in radiopharmaceuticals. Stay ahead of the curve with this in-depth ...
Designing HCP engagement for the next normal | pharmaphorum
WEB5 days ago · Life sciences companies’ engagement with HCPs has changed significantly in the past 12 months, as the COVID-19 pandemic struck. Restrictions to in-person face-to-face interactions have resulted ...
pharmaphorum - The Deep Dive Digital Magazine has fresh …
WEBFeb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
News | Timely industry updates for pharma and biotech leaders
WEBpharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
Deep-Dive | pharmaphorum
WEBAs Ozempic’s viral weight-loss fame skyrockets, shortages and counterfeit dangers loom, but is the industry ready to tackle the “trendification” of treatment?
Threats impacting the pharmaceutical industry in 2024
WEB1 day ago · Explore the potential threats and risks impacting the pharmaceutical industry in 2024, including considerations such as protests, risk analysis, and the influence of environmental, social, and ...
5 years of biosimilars in the US: what have we learned?
WEBSep 18, 2024 · In fact, it has taken Zarxio five years to achieve a 32 percent market share within the Filgrastim market. 3 In order to increase interest across products, we must create a level playing field for ...